CNS Summit 2026
Neuroscience sponsors are navigating increasing complexity across development, evidence generation and commercialization. As stakeholder expectations continue to rise, organizations are looking for ways to align clinical, medical affairs, market access and commercial strategies earlier to maximize asset value and support long-term success.
At the same time, emerging areas such as psychedelic treatments are creating new opportunities and challenges, requiring specialized expertise, operational flexibility, and integrated evidence planning differentiation, access and adoption.
The Syneos Health Experience at CNS Summit 2026
Meet us at booth #811 to explore the future of neuroscience drug development and learn how our integrated teams help sponsors accelerate development and commercialization strategies across the product lifecycle.
Featured Session
Main Stage with Greg Licholai
Greg Licholai, Chief Medical Officer, Syneos Health
Main Stage
Greg Licholai
CMO, Syneos Health
Join our Chief Medical Officer (CMO) for an engaging main-stage discussion on a China-focused future of clinical development in neuroscience.
Back on the Mic With the Syneos Health Podcast at Booth #810
We’re bringing The Syneos Health Podcast back to the conference floor for its third year at booth #810, capturing fast takes, fresh ideas and fearless conversations on what’s next in neuroscience.
